Increased cerebrospinal fluid Fas (Apo-1) levels in Alzheimer's disease -: Relationship with IL-6 concentrations

被引:72
作者
Martínez, M
Fernández-Vivancos, E
Frank, A
De la Fuente, M
Hernanz, A [1 ]
机构
[1] Hosp Univ La Paz, Dept Biochem, Madrid 28046, Spain
[2] Hosp Univ La Paz, Dept Pathol, Madrid 28046, Spain
[3] Hosp Univ La Paz, Dept Neurol, Madrid 28046, Spain
[4] Univ Complutense Madrid, Fac CC Biol, Dept Anim Physiol, Madrid, Spain
关键词
Fas; apoptosis; cytokines; cerebrospinal fluid; Alzheimer's disease;
D O I
10.1016/S0006-8993(00)02363-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing lines of evidence suggest a role of apoptosis in the neurodegeneration associated with Alzheimer's disease, in which it has been implicated in increasing the expression of p53 and Fas. On the other hand, inflammatory cytokines have also been implicated as important factors in the progression of neuronal damage in this disease. In an attempt to investigate the possible in vivo relationship between programmed cell death and the inflammatory response in patients with dementia of the Alzheimer type (DAT), we measured the levels of soluble Fas, interleukin-1 beta (IL-1 beta) and IL-6 in cerebrospinal fluid (CSF) from ten DAT patients and ten age-matched controls. Our results show a significant increase in IL-6 and soluble Fas concentrations in the CSF of DAT patients compared with those from nondemented controls. Moreover, linear regression analysis demonstrated a significant correlation (r=0.703; P<0.05) between soluble Fas and IL-6 levels in the CSF in DAT patients. These results suggest that Fas is implicated in the inflammatory response observed in Alzheimer's brains. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:216 / 219
页数:4
相关论文
共 33 条
  • [1] Aisen PS, 1997, GERONTOLOGY, V43, P143
  • [2] Albanese J, 1998, BLOOD, V91, P3862
  • [3] CYTOKINES IN ALZHEIMERS-DISEASE
    ALTSTIEL, LD
    SPERBER, K
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1991, 15 (04) : 481 - 495
  • [4] THE PARTICIPATION OF INTERLEUKIN-6 IN THE PATHOGENESIS OF ALZHEIMERS-DISEASE
    BAUER, J
    GANTER, U
    STRAUSS, S
    STADTMULLER, G
    FROMMBERGER, U
    BAUER, H
    VOLK, B
    BERGER, M
    [J]. RESEARCH IN IMMUNOLOGY, 1992, 143 (06): : 650 - 656
  • [5] CD95-CD95L: can the brain learn from the immune system?
    Becher, B
    Barker, PA
    Owens, T
    Antel, JP
    [J]. TRENDS IN NEUROSCIENCES, 1998, 21 (03) : 114 - 117
  • [6] Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    BlumDegen, D
    Muller, T
    Kuhn, W
    Gerlach, M
    Przuntek, H
    Riederer, P
    [J]. NEUROSCIENCE LETTERS, 1995, 202 (1-2) : 17 - 20
  • [7] CHOLINERGIC AGONISTS AND INTERLEUKIN-1 REGULATE PROCESSING AND SECRETION OF THE ALZHEIMER BETA/A4 AMYLOID PROTEIN-PRECURSOR
    BUXBAUM, JD
    OISHI, M
    CHEN, HI
    PINKASKRAMARSKI, R
    JAFFE, EA
    GANDY, SE
    GREENGARD, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10075 - 10078
  • [8] PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE
    CHENG, JH
    ZHOU, T
    LIU, CD
    SHAPIRO, JP
    BRAUER, MJ
    KIEFER, MC
    BARR, PJ
    MOUNTZ, JD
    [J]. SCIENCE, 1994, 263 (5154) : 1759 - 1762
  • [9] Choi C, 1999, J IMMUNOL, V162, P1889
  • [10] Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
    Ciusani, E
    Frigerio, S
    Gelati, M
    Corsini, E
    Dufour, A
    Nespolo, A
    La Mantia, L
    Milanese, C
    Massa, G
    Salmaggi, A
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 82 (01) : 5 - 12